ENTR1P2

Across TCGA pan-cancer cohorts, ENTR1P2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated ENTR1P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ENTR1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ENTR1P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCEC show a favorable association.

KIRC, ACC, and BLCA are the cancer types where ENTR1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	IV	0.292	0.575	<.001	81	view →
ACC	OS	Quartile	All	0.516	0.856	<.001	67	view →
BLCA	OS	Tertile	All	0.638	0.766	.010	42	view →
SKCM	OS	Median	III,IV	0.787	0.613	.006	40	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
LIHC	DFS	Tertile	All	0.269	0.545	.001	34	view →
UCEC	DFS	Median	III,IV	0.864	0.724	.005	20	view →
UVM	OS	Quartile	III,IV	0.215	0.837	.006	17	view →
THCA	OS	Quartile	II,III,IV	0.688	0.953	.006	16	view →
LGG	DFS	Quartile	All	0.631	0.772	.001	13	view →
SARC	OS	Quartile	All	0.730	0.886	.004	13	view →
LUSC	DFS	Tertile	All	0.808	0.706	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

ENTR1P2–KIRC (DFS)

Open the KIRC breakdown →